XFOR icon

X4 Pharmaceuticals

16 hedge funds and large institutions have $161M invested in X4 Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.36%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AI
1
Alphabet Inc
California
$34.6M 451,362 +451,362 New
NMC
2
NEA Management Company
Maryland
$25.5M 2,000,000 +2,000,000 New
SHI
3
SV Health Investors
Massachusetts
$23.8M 1,868,961 +1,868,961 New
PVMCV
4
Polaris Venture Management Co V
Massachusetts
$23.8M 1,868,957 +1,868,957 New
O
5
OrbiMed
New York
$23.8M 1,868,966 +1,868,966 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$19.8M 1,548,900 +1,548,900 New
SFM
7
Sphera Funds Management
Israel
$3.44M 269,268 +269,268 New
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$2.97M 232,596 +232,596 New
DM
9
Deerfield Management
New York
$1.68M 131,548 +131,548 New
LCM
10
Landscape Capital Management
New Jersey
$504K 39,529 +39,529 New
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$460K 36,040 +36,040 New
Millennium Management
12
Millennium Management
New York
$299K 23,446 +23,446 New
UBS Group
13
UBS Group
Switzerland
$270K 21,150 +21,150 New
MIM
14
Monashee Investment Management
Massachusetts
LCM
15
Laurion Capital Management
New York
$191K 15,000 +15,000 New
Citigroup
16
Citigroup
New York
$9K 701 +701 New
Morgan Stanley
17
Morgan Stanley
New York
$0 22 +22 New